哺乳期高风险筛查中乳腺MRI的诊断效能
回顾性分析2008年4月至2024年3月哺乳期高风险筛查乳腺MRI。哺乳期MRI背景实质强化显著(82%为明显强化),BI-RADS 3类比例高于对照组(28% vs 7%),特异度60%、敏感度50%、阳性预测值2.0%、阴性预测值98.6%。作者认为明显背景实质强化限制了筛查效能,但该筛查方式对高风险哺乳期患者仍有意义,放射科医生应熟悉哺乳期乳腺MRI正常表现。
要点
- 哺乳期筛查乳腺MRI中82%(116/142)出现明显背景实质强化。
- 哺乳期BI-RADS 3类率40/142(28%)高于对照组683/8922(7%)。
- 哺乳期筛查MRI敏感度50%(1/2)、特异度60%(72/120)、阳性预测值2.0%(1/49)、阴性预测值98.6%(71/82)。
核心结论
- 哺乳期乳腺MRI高风险筛查的效能受明显背景实质强化限制,导致BI-RADS 3类比例增加和总体特异度降低。
研究设计与样本
- 回顾性研究,纳入2008年4月至2024年3月期间筛查乳腺MRI,哺乳期患者104例共142次检查(中位年龄36.0±6.0岁),对照组为非哺乳年轻患者8922次检查;诊断效能基于活检参考或1年影像随访计算。
关键影像表现/征象
- 哺乳期检查中82%(116/142)出现明显背景实质强化。
- 哺乳期检查背景实质强化等级高于近期停止哺乳者(p < 0.001)。
诊断标准与关键数值
- 哺乳期筛查MRI敏感度50%(1/2)、特异度60%(72/120)、阳性预测值2.0%(1/49)、阴性预测值98.6%(71/82)。
- 哺乳期BI-RADS 3类率40/142(28%)vs 对照组683/8922(7%),p < 0.001。
- 哺乳期BI-RADS 1/2类率88/142(62%)vs 对照组7549/8922(84.6%),p = 0.002。
- 诊断出1例妊娠相关乳腺癌和1例间期癌;MRI引导下活检均阴性(n=13)。
临床应用与阅片要点
- 放射科医生应熟悉哺乳期乳腺MRI的正常表现(作者指出)。
- 尽管效能较低且妊娠相关乳腺癌风险显著,该筛查方式对具有高风险特征的哺乳期患者(如BRCA携带者)仍有意义(作者指出)。
局限性
- 哺乳期乳腺MRI筛查效能受明显背景实质强化限制,导致BI-RADS 3类比例增加和总体特异度降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the diagnostic performance of breast MRI during lactation in the setting of high-risk breast cancer screening.
MATERIALS AND METHODS: Screening breast MRIs performed between April 2008 and March 2024 were retrospectively reviewed. Background parenchymal enhancement (BPE) grade was compared between lactating patients and patients who recently stopped lactating using the Mann-Whitney test. Breast Imaging Reporting and Data System (BI-RADS) scores prevalence rates were compared between lactating patients and controls encompassing young non-lactating patients using the Chi-square test. Diagnostic performance was calculated for patients with a biopsy reference or a 1-year radiologic follow-up.
RESULTS: One-hundred forty-two screening breast MRIs were performed in lactating patients (n = 104, median age, 36.0 ± 6.0 years). Marked BPE appeared in 82% of cases (116/142), with a higher BPE grade in exams performed during lactation as compared with those performed in patients who had recently ceased lactating (p < 0.001). Screening MRIs performed during lactation had a higher rate of BI-RADS 3 scores (40/142, 28% vs. 683/8922, 7%, p < 0.001) and a lower rate of BI-RADS 1/2 scores (88/142, 62% vs. 7549/8922, 84.6%, p = 0.002) compared with those performed in controls (n = 8922). One pregnancy-associated breast cancer was detected, and one interval-cancer occurred. All MRI-guided biopsies were negative (n = 13). Screening breast MRI during lactation had 50% sensitivity (1/2), 60% specificity (72/120), 2.0% positive predictive value (1/49), and 98.6% negative predictive value (71/82).
CONCLUSION: The efficacy of breast MRI for high-risk screening during lactation is limited by prominent BPE, leading to an increased rate of BI-RADS 3 categorization and diminished overall specificity.
KEY POINTS: Question Studies on breast MRI during lactation were solely focused on studies conducted in patients with known cancer but not in the screening setting. Findings Screening breast MRI during lactation usually results in marked background parenchymal enhancement, negatively impacting its diagnostic performance. Clinical relevance Despite the lower performance, and amidst the significant risk of pregnancy-associated breast cancer, this screening approach remains relevant for lactating patients with high-risk profiles, such as BReast Cancer (BRCA) carriers. Radiologists should be familiar with the normal appearance of breast MRI during lactation.
引用
- Nissan N, Gluskin J, Ochoa-Albiztegui RE, et al. Performance of breast MRI for high-risk screening during lactation. Eur Radiol. 2024. PMID: 39480534. doi:10.1007/s00330-024-11091-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。